Partner Judy Waltz will be speaking at the American Conference Institute’s 4th National Pharmaceutical Counsel’s Guide to Off-Label Communications: Staying Within the Bounds of Lawful Scientific Exchange, July 17 – 18, 2007 at the Park Hyatt Philadelphia at the Bellevue in Philadelphia, PA.
Topic: Tackling the Reimbursement Issues Associated with Off-label Users Date: July 18, 2007 Time: 2:00 p.m. – 3:00 p.m.
Evaluating Medicare Part D and off-label coverage implications
Communicating with payors: what are the legal parameters?
Understanding how CMS reimbursement decisions will impact decisions in the Medicaid and private payor market
Reviewing Medicaid compendia processes and standards
Disseminating data for formulary decision-making
Avoiding traps in discounts and pricing arrangements
Speakers:
John S. McInnes, MD, JD, Associate, Arnold & Porter LLP (Washington, DC)
Judy Waltz, Partner, Foley & Lardner LLP (San Francisco, CA)
